Buys
Open market- Shares
- +50,000
- Avg price
- $1.50
- Total value
- +$75,000
Oliver Rolf Baumann - Director at Veraxa Biotech Holding AG
Issuer-level insider activity
- Role
- Director
- Issuer ticker
- VRXA, VRXAW on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Oliver Rolf Baumann in Veraxa Biotech Holding AG
Sells
Open market- Shares
- Avg price
- Total value
Net
Past year- Shares
- +50,000
- Share %
- 100%
- Total value
- +$75,000
Reported holdings for Oliver Rolf Baumann in Veraxa Biotech Holding AG
Form 4 holding
Director
Veraxa Biotech AG - Post de-SPAC
- Security class
- Ordinary Shares
- Shares / value
- 5,773,618
- Estimated value
- $8,660,427
- Report date
- 27 Aug 2026
- Price
- $1.50
- Ownership
- Indirect
Form 4 holding
Director
Veraxa Biotech Holding AG
- Security class
- Ordinary Shares
- Shares / value
- 5,723,618
- Estimated value
- Report date
- 09 Jun 2026
- Price
- Ownership
- Indirect ownership through Akira Holding AG
Transaction history for Oliver Rolf Baumann in Veraxa Biotech Holding AG
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.